20250703-开源证券-开源晨会_6页_605kb

报告摘要

Key Highlights: Southbound funds had a strong net inflow in 2025, with cumulative inflows reaching 91% of the 2024 full-year total by June. The Hong Kong market saw overall volatility and upward movement in June, with gains in sectors like有色金属, electronics, and defense. The equities premium combination achieved a 0.8% excess return in June, with plans to increase allocation to growth-oriented stocks for July. Focused on factors like profitability and market trends to drive performance.

Power Equipment and Renewable Energy: Central government policies, including supply-side reforms for the photovoltaic industry, aim to address overcapacity and promote healthy competition. Opportunities exist in silicon material companies (e.g., QX Technology, Tongwei Shares) and battery-related firms (e.g., Foxsun, Hoshine Energy), driven by BEG advancements and alternative material integrations.
Pharmaceuticals: Adi Pharmaceutical demonstrated strong performance in HIV treatments with significant sales growth, supported by stock option incentives. The company maintains a "buy" rating with positive outlook for expansion in HIV treatment and prevention, along with potential from new product lines, leading to upwardly revised financial forecasts.

展开完整摘要